A NEW IDEA ON GLAUKOS $GKOS #IPO
This post was just published on ZYX Buy Change Alert. Glaukos (GKOS) sells micro-scale surgical devices for treating glaucoma. It has a new IPO which will
Unrivaled Performance In Bull And Bear Markets. FREE TRIALS.
|
Proven Track Record of Most Accurate Analysis
Proven Track Record
of Most Accurate Analysis
The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.
The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.
This post was just published on ZYX Buy Change Alert. Glaukos (GKOS) sells micro-scale surgical devices for treating glaucoma. It has a new IPO which will
This post was just published on ZYX Buy Change Alert. JPM is long from $34.14. As of this writing it is trading at $69.58. We are raising
This post was just published on ZYX Buy Change Alert. FIT is long from $20. As of this writing it is trading at $37.40. 50% of
(The Weekly Digest reproduces the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers. )
Typically, investors pay a lot of money to their brokers. The time is ripe for investors to now make money off their brokers. Here are
This post was just published on ZYX Buy Change Alert. BPMC is long from $19.20. As of this writing it is trading at $36. Consider taking profits
This post was just published on ZYX Buy Change Alert. FIT is long from $20. 100% of the full core position size is being held. Consider
This post was just published on ZYX Buy Change Alert. FITBIT IPO was priced at $20 per share. The symbol is FIT. 100% of the full